Intensity of statin therapy in primary and secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Adding CME Category::Cardiology) |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==High-, Moderate-, and Low-Intensity Statin Therapy== | ==2013 ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention== | ||
===High-, Moderate-, and Low-Intensity Statin Therapy== | |||
{| {{table}} | {| {{table}} |
Revision as of 18:26, 28 October 2016
Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2013 ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention
=High-, Moderate-, and Low-Intensity Statin Therapy
High-Intensity Statin Therapy | Moderate-Intensity Statin Therapy | Low-Intensity Statin Therapy |
Atorvastatin (40†)–80 mg Rosuvastatin 20 (40) mg |
Atorvastatin 10 (20) mg Rosuvastatin (5) 10 mg Simvastatin 20–40 mg‡ Pravastatin 40 (80) mg Lovastatin 40 mg Fluvastatin XL 80 mg Fluvastatin 40 mg bid Pitavastatin 2–4 mg |
Simvastatin 10 mg Pravastatin 10–20 mg Lovastatin 20 mg Fluvastatin 20–40 mg Pitavastatin 1 mg |